GeneGlobe ID: PHS-3100Z | Cat. No.: | QIAseq Targeted DNA Pro Panels

QIAseq Targeted DNA Pro Human Comprehensive Cancer Focus Panel

Kit containing ALL reagents (except indexes) for targeted DNA sequencing

Select a variant to see the price

Product Specification

Target List

Covers specific hotspots of the targeted genes based on the Human GRCh38 genome build

Bladder Cancers
Adenocarcinomas​
KRASTP53 (p53)
Transitional Cell Carcinomas​
AKT1ARID1AATMBRAFCCND1CCNE1CDKN2A (P16INK4A)CTNNB1ERBB2 (HER-2, NEU)ERBB3ERCC2 (XPD)FGFR2FGFR3HRASKDM6AKRASPIK3CA (p110-alpha)PTENRB1TP53 (p53)
Brain Cancers
Anaplastic Glial Tumors​
PTENTP53 (p53)
Astrocytomas​
BRAFCHEK2 (RAD53)FGFR1IDH1KRASPTPN11TP53 (p53)
Ependymomas​
H3-3ANF2
Glioblastomas​
APCBCORBRAFCREBBP (CBP)EGFR (ERBB1)H3-3AIDH1MLH1MSH2MTORNRASPIK3CA (p110-alpha)PMS2PMS2CLPTENTERTTP53 (p53)
Gliomas​
ACVR1 (ALK2)BRCA2CHEK2 (RAD53)FGFR1H3-3APIK3CA (p110-alpha)PTENTP53 (p53)
High-Grade Gliomas​
BRAFEGFR (ERBB1)IDH1
Medulloblastomas​
BRCA2CREBBP (CBP)FGFR1IDH1MSH2NRASPIK3CA (p110-alpha)PTCH2SUFUTP53 (p53)
Meningiomas​
NF2PTEN
Oligodendrogliomas​
IDH1MSH2TERT
Breast Cancers
Carcinomas​
ATMBARD1BRCA1BRCA2BRIP1CDH1 (E-Cadherin)CDK12CDK4CHEK1CHEK2 (RAD53)EGFR (ERBB1)ERBB2 (HER-2, NEU)ESR1 (ERα)FANCLFBXW7KIT (CD117)KRASMETMLH1MLH3MSH2MSH3MSH6PALB2PDGFRAPIK3CA (p110-alpha)PMS1PMS2RAD51BRAD51CRAD51DRAD54LSF3B1
Metastatic Breast Cancers​
AKT1BRCA1BRCA2ERBB2 (HER-2, NEU)ERBB3ESR1 (ERα)PALB2PIK3CA (p110-alpha)PTEN
Mismatch Repair (MMR) Genes​
MLH1MSH2MSH6PMS2
Colorectal Cancers
Adenocarcinomas​
APCARID1AATMBARD1BRAFBRCA1BRCA2BRIP1CDK12CDKN2A (P16INK4A)CHEK1CHEK2 (RAD53)CTNNB1EGFR (ERBB1)ERBB2 (HER-2, NEU)ERBB3FANCLFBXW7GNASKIT (CD117)KRASMAP2K1METMLH1MLH3MSH2MSH3MSH6MYCNRASPALB2PDGFRAPMS1PMS2PMS2CLPOLEPTENRAD51BRAD51CRAD51DRAD54LRETRNF43SMAD4 (MADH4)TCF7L2TGFBR2TP53 (p53)
Metastatic Colorectal Cancers​
AKT1ATMBRAFERBB2 (HER-2, NEU)KRASMETNRASPIK3CA (p110-alpha)
Mismatch Repair (MMR) Genes​
MLH1MSH2MSH6PMS2PMS2CL
Other Colorectal Cancer Genes​
DPYDERCC1TYMSUGT1A1
Gastric Cancers
Adenocarcinomas​
APCARID1ACDKN2A (P16INK4A)CTNNB1ERBB2 (HER-2, NEU)ERBB3FBXW7GNASKMT2DKRASMYCPIK3CA (p110-alpha)PTENRNF43SMAD4 (MADH4)TP53 (p53)
Adenomas​
APCCTNNB1GNASKRAS
Gastrointestinal Stromal Tumors (GIST)​
BRAFKIT (CD117)PDGFRA
Other Gastric Cancer Genes​
CDH1 (E-Cadherin)MET
Liver Cancers
Advanced Cholangiocarcinomas​
BRAFIDH1
Hepatoblastomas​
CTNNB1TP53 (p53)
Hepatocellular Carcinomas​
ALBAPCAPOBARID1AARID2AXIN1CCND1CDKN2A (P16INK4A)CREBBP (CBP)CTNNB1IDH1IDH2JAK1KEAP1KRASMYCNFE2L2NRASPIK3CA (p110-alpha)RB1RIT1TERTTP53 (p53)TSC2
Lung Cancers
Adenocarcinomas​
ABL1ALKATMBRAFCDK4CDKN2A (P16INK4A)CTNNB1EGFR (ERBB1)ERBB2 (HER-2, NEU)KRASMAP2K1METNRASNTRK1PIK3CA (p110-alpha)PTENRETROS1TP53 (p53)TSC2
Malignant Pleural Mesotheliomas​
NF2
Non-Small Cell Lung Cancers (NSCLC)​
ALKATMBARD1BRAFBRCA1BRCA2BRIP1CDK12CDK4CDKN2A (P16INK4A)CHEK1CHEK2 (RAD53)CTNNB1EGFR (ERBB1)ERBB2 (HER-2, NEU)FANCLKIT (CD117)KRASMAP2K1METMLH1MLH3MSH2MSH3MSH6NRASPALB2PDGFRAPIK3CA (p110-alpha)PMS1PMS2PTENRAD51BRAD51CRAD51DRAD54LRETROS1TP53 (p53)
Small Cell Lung Cancers (SCLC)​
NTRK1PIK3CA (p110-alpha)PTENRB1TP53 (p53)
Squamous Cell Carcinomas​
BRAFCDKN2A (P16INK4A)EGFR (ERBB1)NTRK1PIK3CA (p110-alpha)PTENTP53 (p53)TSC2
Melanomas
Cutaneous Melanomas​
KRASMLH1MLH3MSH2MSH6NRAS
Malignant Melanomas​
AKT3ARID2BRAFCCND1CDK4CDKN2A (P16INK4A)CREBBP (CBP)CTNNB1ERBB4EZH2GNA11GNAQGRIN2AHRASIDH1KIT (CD117)KRASMAP2K1MAP2K2 (MEK2)MITFNF1NRASPIK3CA (p110-alpha)PPP6CPTENRAC1RAF1RB1TERTTP53 (p53)
Mucosal Melanomas​
BRAFKIT (CD117)MLH1MLH3MSH2MSH6NRAS
Ocular Melanomas​
MLH1MLH3MSH2MSH6
Uveal Melanomas​
ATMBAP1BRCA1BRCA2CDK12EGFR (ERBB1)FANCLKRASMLH1MLH3MSH2MSH6NRASPALB2PLCB4
Other Melanoma Genes​
BARD1BRIP1CHEK1CHEK2 (RAD53)PDGFRARAD51BRAD51CRAD51D
Myeloid Neoplasms
Acute Lymphoblastic Leukemia (ALL)​
ABL1BRAFBTKCDKN2A (P16INK4A)CREBBP (CBP)ETV6FBXW7FLT3HRASJAK1JAK2JAK3KMT2AKRASMYCNOTCH1NRASPTENPTPN11RUNX1 (AML1)SF3B1TP53 (p53)
Acute Myeloid Leukemia (AML)​
ASXL1ATRXBRCA1BRCA2CBLBCBLCCEBPADNMT3AETV6FLT3GATA1GATA2GNASHRASIDH1IDH2JAK2KIT (CD117)KMT2AKRASMTORNPM1NRASPDGFRAPTPN11RUNX1 (AML1)SF3B1SMC1ATET2TP53 (p53)U2AF1WT1
Acute Promyelocytic Leukemia (APML; APL)​
CEBPANPM1RUNX1 (AML1)
Atypical Chronic Myeloid Leukemia (aCML)​
ASXL1CBLCEBPAEZH2FLT3JAK2KRASNPM1NRASRUNX1 (AML1)SETBP1SRSF2TET2U2AF1
Chronic Lymphocytic Leukemia (CLL)​
ATRXBCL2BRAFCBLBGNASGNB1MYD88NOTCH1NRASPTPN11SF3B1TP53 (p53)XPO1
Chronic Myeloid Leukemia (CML)​
ABL1ASXL1BCORBRAFCBLCREBBP (CBP)DNMT3AEZH2IDH1IDH2JAK2KRASNPM1NRASRUNX1 (AML1)TET2TP53 (p53)WT1
Chronic Myelomonocytic Leukemia (CMML)​
ASXL1BCORBCORL1CBLCEBPADNMT3AEZH2FLT3IDH1IDH2JAK2KIT (CD117)KRASMPLNF1NPM1NRASPHF6PTPN11RUNX1 (AML1)SETBP1SF3B1SRSF2STAG2TET2TP53 (p53)U2AF1ZRSR2
Hairy Cell Leukemia​
BRAFTP53 (p53)
Juvenile Myelomonocytic Leukemia​
CBLKRASNRASPTPN11
Acute Lymphocytic Lymphomas​
BTKCDKN2A (P16INK4A)MYCNOTCH1SF3B1TP53 (p53)
B Cell Lymphomas​
BCL6BRAFCHEK2 (RAD53)EZH2MYD88TP53 (p53)
Burkitt Lymphomas​
CBLBGNA13MTORMYC
Diffuse Large B Cell Lymphomas​
B2MBCL2CBLBGNA13KMT2DMTORPIM1SOCS1TNFAIP3
Follicular Lymphomas​
ARID1ABCL2CARD11CREBBP (CBP)EZH2KMT2D
Mantle Cell Lymphomas​
ATM
Marginal Zone Lymphomas​
MYD88TNFAIP3TP53 (p53)
Mucosa-Associated Lymphoid Tissue (MALT) Lymphomas​
TNFAIP3
Non-Hodgkin Lymphomas​
BRAFNRASPIK3CA (p110-alpha)TP53 (p53)
Primary Cutaneous Lymphomas​
CD79BMYD88
Small Lymphocytic Lymphomas​
ATRXBCL2CBLBGNASXPO1
T Cell Lymphomas​
ATMCBLBDNMT3AIDH1IDH2JAK1JAK3RHOASTAT3STAT5BTET2
Myelodysplastic Syndromes​
ASXL1ATRXBCORBCORL1CALRCBLCEBPACSF3R (GM-CSFR)DNMT3AETV6EZH2FLT3GATA2GNASGNB1IDH1IDH2JAK2JAK3KIT (CD117)KRASMPLNF1NPM1NRASPHF6PPM1DPTPN11RAD21RUNX1 (AML1)SETBP1SF3B1SMC3SRSF2STAG2STAT3TET2TP53 (p53)U2AF1WT1ZRSR2
Myeloproliferative Neoplasms​
ASXL1CALRCBLDNMT3AEZH2IDH1IDH2JAK2MPLRUNX1 (AML1)SF3B1SRSF2TP53 (p53)U2AF1
Essential Thrombocythemia​
ASXL1CBLIDH2JAK2MPLSF3B1TET2TP53 (p53)
Multiple Myeloma​
ATMBARD1BRAFBRCA1BRCA2BRIP1CHEK1CHEK2 (RAD53)EGFR (ERBB1)ERBB2 (HER-2, NEU)FANCLFGFR3IDH1IDH2KIT (CD117)KRASMETNRASPALB2PDGFRARAD51BRAD51CRAD51DRETTP53 (p53)
Plasma Cell Myeloma​
HRASMTOR
Polycythemia Vera​
ASXL1DNMT3AEZH2IDH1JAK2NRASTET2TP53 (p53)
Primary Myelofibrosis​
ASXL1CBLDNMT3AEZH2IDH1IDH2JAK2MPLNF1NRASSETBP1SF3B1SRSF2TET2TP53 (p53)
Systemic Mastocytosis​
ASXL1CBLDNMT3AETV6EZH2IDH2JAK2KIT (CD117)KRASNPM1NRASRUNX1 (AML1)SETBP1SF3B1SRSF2TET2U2AF1
Waldenstrom Macroglobulinemia​
MYD88
Ovarian Cancers
Endometrioid Carcinomas​
CTNNB1POLEPPP2R1A
Epithelial Carcinomas​
ARID1ABRCA1BRCA2CCNE1CHEK2 (RAD53)ERBB2 (HER-2, NEU)KRASPIK3CA (p110-alpha)PTENRB1TP53 (p53)
Granulosa Cell Tumors​
AKT1FOXL2
Mixed Adenosquamous Carcinomas​
AKT1CCNE1ERBB3FANCMFBXW7FGFR2MYCPIK3R1 (p85-ALPHA)POLERB1STK11 (LKB1)
Mucinous Carcinomas​
ERBB3
Serous Carcinomas​
CCNE1ERBB3FANCMFBXW7FGFR2MYCPPP2R1ARB1
Pancreatic Cancers
Adenocarcinomas​
CDKN2A (P16INK4A)MSH6PMS2SMAD4 (MADH4)TP53 (p53)
Advanced Ductal Adenocarcinomas​
BRAFBRCA1BRCA2ERBB2 (HER-2, NEU)KRASPIK3CA (p110-alpha)
Ductal Carcinomas​
APCARID1ACTNNB1ERBB3FBXW7GNASMYCNRASPOLEPTENRNF43TCF7L2
Mismatch Repair (MMR) Genes​
MSH6PMS2
Prostate Cancers
Adenocarcinomas​
APCARBRAFCHEK2 (RAD53)FOXA1HRASIDH1KDM6AKMT2DKRASMED12MYCPIK3R1 (p85-ALPHA)PTENRB1SPOPTP53 (p53)
Advanced Prostate Cancers​
AKT1BRCA2PIK3CA (p110-alpha)PTEN
Ductal Carcinomas​
CTNNB1

Resources

Application Notes (1)
Kit Handbooks (2)
For ultrasensitive targeted next-generation sequencing of DNA for Ion Torrent NGS systems
For ultrasensitive targeted next-generation sequencing (NGS) of DNA for Illumina NGS systems
Safety Data Sheets (1)
Certificates of Analysis (1)
Template Files (1)
Introducing the QIAseq Targeted DNA Pro Human Comprehensive Cancer Focus Panel, a cutting-edge addition to our QIAseq Targeted DNA Pro Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Targeted DNA Pro Human Comprehensive Cancer Focus Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Targeted DNA Pro Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Targeted DNA Pro Human Comprehensive Cancer Focus Panel and elevate your work to new heights.